These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29653222)

  • 1. Gemcitabine loaded microbubbles for targeted chemo-sonodynamic therapy of pancreatic cancer.
    Nesbitt H; Sheng Y; Kamila S; Logan K; Thomas K; Callan B; Taylor MA; Love M; O'Rourke D; Kelly P; Beguin E; Stride E; McHale AP; Callan JF
    J Control Release; 2018 Jun; 279():8-16. PubMed ID: 29653222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined sonodynamic and antimetabolite therapy for the improved treatment of pancreatic cancer using oxygen loaded microbubbles as a delivery vehicle.
    McEwan C; Kamila S; Owen J; Nesbitt H; Callan B; Borden M; Nomikou N; Hamoudi RA; Taylor MA; Stride E; McHale AP; Callan JF
    Biomaterials; 2016 Feb; 80():20-32. PubMed ID: 26702983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation loaded with paclitaxel for the treatment of pancreatic cancer using ultrasound-targeted microbubble destruction.
    Logan KA; Nesbitt H; Callan B; Gao J; McKaig T; Taylor M; Love M; McHale AP; Callan JF
    Eur J Pharm Biopharm; 2021 Aug; 165():374-382. PubMed ID: 34038797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted chemo-sonodynamic therapy treatment of breast tumours using ultrasound responsive microbubbles loaded with paclitaxel, doxorubicin and Rose Bengal.
    Logan K; Foglietta F; Nesbitt H; Sheng Y; McKaig T; Kamila S; Gao J; Nomikou N; Callan B; McHale AP; Callan JF
    Eur J Pharm Biopharm; 2019 Jun; 139():224-231. PubMed ID: 30959180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound targeted microbubble destruction using docetaxel and Rose Bengal loaded Microbubbles for targeted Chemo-Sonodynamic therapy treatment of prostate cancer.
    McKaig T; Logan K; Nesbitt H; Callan B; McKeown S; O'Sullivan JM; Kelly P; O'Rourke D; McHale AP; Callan JF
    Eur J Pharm Biopharm; 2023 Nov; 192():196-205. PubMed ID: 37858804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetically responsive microbubbles as delivery vehicles for targeted sonodynamic and antimetabolite therapy of pancreatic cancer.
    Sheng Y; Beguin E; Nesbitt H; Kamila S; Owen J; Barnsley LC; Callan B; O'Kane C; Nomikou N; Hamoudi R; Taylor MA; Love M; Kelly P; O'Rourke D; Stride E; McHale AP; Callan JF
    J Control Release; 2017 Sep; 262():192-200. PubMed ID: 28764995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UTMD-Promoted Co-Delivery of Gemcitabine and miR-21 Inhibitor by Dendrimer-Entrapped Gold Nanoparticles for Pancreatic Cancer Therapy.
    Lin L; Fan Y; Gao F; Jin L; Li D; Sun W; Li F; Qin P; Shi Q; Shi X; Du L
    Theranostics; 2018; 8(7):1923-1939. PubMed ID: 29556365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effect of VEGFR2-targeted microbubble destruction with gemcitabine using an endoscopic ultrasound probe: In vivo mouse pancreatic ductal adenocarcinoma model.
    Shimamoto N; Ito M; Chiba M; Honma S; Imazu H; Sumiyama K
    Hepatobiliary Pancreat Dis Int; 2020 Oct; 19(5):478-485. PubMed ID: 32265136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sonoporation-enhanced chemotherapy significantly reduces primary tumour burden in an orthotopic pancreatic cancer xenograft.
    Kotopoulis S; Delalande A; Popa M; Mamaeva V; Dimcevski G; Gilja OH; Postema M; Gjertsen BT; McCormack E
    Mol Imaging Biol; 2014 Feb; 16(1):53-62. PubMed ID: 23877869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
    Chaudhary AK; Mondal G; Kumar V; Kattel K; Mahato RI
    Cancer Lett; 2017 Aug; 402():1-8. PubMed ID: 28536008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Effects of Microbubbles Added to Combined High-Intensity Focused Ultrasound and Chemotherapy in a Pancreatic Cancer Xenograft Model.
    Yu MH; Lee JY; Kim HR; Kim BR; Park EJ; Kim HS; Han JK; Choi BI
    Korean J Radiol; 2016; 17(5):779-88. PubMed ID: 27587968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting a Rose Bengal-bearing, oxygen-producing nanoparticle for SDT and associated immune-mediated therapeutic effects in the treatment of pancreatic cancer.
    Nicholas D; Nesbitt H; Farrell S; Logan K; McMullin E; Gillan T; Kelly P; O'Rourke D; Porter S; Thomas K; O'Hagan BMG; Nomikou N; Callan B; Callan JF; McHale AP
    Eur J Pharm Biopharm; 2021 Jun; 163():49-59. PubMed ID: 33798727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Delivery of Photopolymerizable Nanogels Loaded with Gemcitabine for Pancreatic Cancer Therapy: Formulation Design, and in vitro and in vivo Evaluations.
    Yugatama A; Huang YL; Hsu MJ; Lin JP; Chao FC; Lam JKW; Hsieh CM
    Int J Nanomedicine; 2024; 19():3753-3772. PubMed ID: 38686338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bitter melon juice intake with gemcitabine intervention circumvents resistance to gemcitabine in pancreatic patient-derived xenograft tumors.
    Dhar D; Raina K; Kumar D; Wempe MF; Bagby SM; Pitts TM; Orlicky DJ; Agarwal C; Messersmith WA; Agarwal R
    Mol Carcinog; 2020 Oct; 59(10):1227-1240. PubMed ID: 32816368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists.
    Morimoto M; Matsuo Y; Koide S; Tsuboi K; Shamoto T; Sato T; Saito K; Takahashi H; Takeyama H
    BMC Cancer; 2016 May; 16():305. PubMed ID: 27175473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer.
    Cosco D; Bulotta A; Ventura M; Celia C; Calimeri T; Perri G; Paolino D; Costa N; Neri P; Tagliaferri P; Tassone P; Fresta M
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):1009-20. PubMed ID: 19263052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcitabine-Phospholipid Complex Loaded Lipid Nanoparticles for Improving Drug Loading, Stability, and Efficacy against Pancreatic Cancer.
    Dora CP; Kushwah V; Yadav V; Kuche K; Jain S
    Mol Pharm; 2024 Jun; 21(6):2699-2712. PubMed ID: 38747900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound and microbubble assisted drug delivery - A clinical pharmacological perspective.
    Bjånes TK; Riedel B; Schjøtt J
    Pharmacol Res; 2021 Mar; 165():105475. PubMed ID: 33524538
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer cell membrane-modified Soluplus® micelles for gemcitabine delivery to pancreatic cancer using a prodrug approach.
    Pereira-Silva M; Diaz-Gomez L; Blanco-Fernandez B; Ferreirós A; Veiga F; Concheiro A; Paiva-Santos AC; Alvarez-Lorenzo C
    Int J Pharm; 2024 Sep; 662():124529. PubMed ID: 39084580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the cytotoxic effects of combined ultrasound, microbubble and nucleoside analog combinations on pancreatic cells in vitro.
    Mariglia J; Momin S; Coe IR; Karshafian R
    Ultrasonics; 2018 Sep; 89():110-117. PubMed ID: 29775835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.